UY29737A1 - Aciltriptofanoles - Google Patents

Aciltriptofanoles

Info

Publication number
UY29737A1
UY29737A1 UY29737A UY29737A UY29737A1 UY 29737 A1 UY29737 A1 UY 29737A1 UY 29737 A UY29737 A UY 29737A UY 29737 A UY29737 A UY 29737A UY 29737 A1 UY29737 A1 UY 29737A1
Authority
UY
Uruguay
Prior art keywords
aciltriptofanoles
acyltriptophanols
fertility
osteoporosis
men
Prior art date
Application number
UY29737A
Other languages
English (en)
Inventor
Dirk Kosemund
Lars Wortmann
Aewed Cleve
Bernd Menzenbach
Hans-Peter Muhn
Germot Langer
Anna Schrey
Ronald Kuehne
Markus Koppitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY29737A1 publication Critical patent/UY29737A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a aciltriptofanoles de la fórmula general I, EN DONDE q,x,y,w,r1,r2,r3,r4,r5,r8 tienen el significado indicado en la descripción . Los compuestos según la invención son eficaces antagonistas de FSH y se pueden usar, por ejemplo, para el control de la fertilidad en el hombre o en la mujer, o para la prevención y/o el tratamiennto de osteoporosis.
UY29737A 2005-08-10 2006-08-10 Aciltriptofanoles UY29737A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005038632A DE102005038632B4 (de) 2005-08-10 2005-08-10 Acyltryptophanole

Publications (1)

Publication Number Publication Date
UY29737A1 true UY29737A1 (es) 2007-02-28

Family

ID=37681170

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29737A UY29737A1 (es) 2005-08-10 2006-08-10 Aciltriptofanoles

Country Status (7)

Country Link
AR (1) AR056190A1 (es)
DE (1) DE102005038632B4 (es)
DO (1) DOP2006000187A (es)
GT (1) GT200600365A (es)
PE (1) PE20070406A1 (es)
TW (1) TW200716098A (es)
UY (1) UY29737A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008025893B4 (de) * 2008-05-26 2014-09-18 Technische Universität Dresden Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren

Also Published As

Publication number Publication date
DE102005038632B4 (de) 2008-03-27
DOP2006000187A (es) 2007-03-15
GT200600365A (es) 2007-04-02
DE102005038632A1 (de) 2007-02-15
AR056190A1 (es) 2007-09-26
TW200716098A (en) 2007-05-01
PE20070406A1 (es) 2007-05-12

Similar Documents

Publication Publication Date Title
WO2007017289A3 (en) Acyltryptophanols for fertility control
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
ECSP099413A (es) COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO
HN2012001162A (es) Triazolopiridinas
DOP2009000094A (es) Inhibidores de la proteasa ns3 del hcv
ATE433447T1 (de) Pyrimiidinverbindungen
WO2009016253A3 (en) Cyanomethyl substituted n-acyl tryptamines
JO3408B1 (ar) مركبات بترين سلفون اميد ثيازول و أوكسازول
NI200900069A (es) Inhibidores de la proteasa ns3 del hcv
ATE537170T1 (de) Cgrp-rezeptorantagonisten
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
TW201129567A (en) Materials for organic electroluminescent devices
GT200500179BA (es) Mezclas sinergistas de agentes de antranilamida para el control de plagas de invertebrados
ES2530991T3 (es) Procedimiento para la obtención de betamiméticos
ATE523487T1 (de) 2-methylen-1-alpha-dihydroxy-19,21-dinor-vitami - d3-analoga und ihre anwendung
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
DK1696905T3 (da) Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson
EP1802372A4 (en) CGRP RECEPTOR ANTAGONISTS)
EP1856100A4 (en) CGRP RECEPTOR ANTAGONISTS
ECSP044999A (es) Agentes antidiabeticos
ATE554774T1 (de) 2-methylen-19-nor-(20s-24epi)-1alpha,25- dihydrovitamin-d2
DK1373220T3 (da) Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion
DE602006008788D1 (de) Verbindungen
ATE395827T1 (de) 5-iodtetrazole

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160830